VACCINES2026SCIENTIFIC SESSIONS
Â
1. Vaccine Technologies and Platforms
- mRNA vaccines
- Vector-based vaccines
- Nanoparticle vaccines
- Adjuvants
- Emerging technologies
2. Diseases
i). Common and Widespread Diseases
- Respiratory Syncytial Virus (RSV)
- Influenza
- COVID-19
- Pneumococcal
- Tuberculosis
- Whooping cough
ii)Emerging and Re-Emerging Diseases
- Zika
- Ebola
- Marburg
- Lassa fever
- Dengue
iii)Bacterial and Viral Diseases
- DTP (Diphtheria, Tetanus, Pertussis)
- Pneumococcal
- Meningococcal
- MMR (Measles, Mumps, Rubella)
- Hepatitis
- HPV (Human Papillomavirus)
- Chickenpox
3. Immune Characterization
- Antibody production
- Neutralization assays
- Immune markers
- Cytokine profiles
- Monoclonal antibodies (mAbs)
- T-cell activation and profiling
- B-cell memory responses
- Epitope mapping and specificity
- Innate immune responses (e.g., NK cells, macrophages)
- Cellular immune assays (e.g., ELISPOT, flow cytometry)
4. Vaccine Development
- Preclinical studies
- Clinical trials (Phase I, II, and III)
- Regulatory review and approval
- Manufacturing and scale-up
- Quality control
- Post-market surveillance
5. Conjugate Vaccines
- Recombinant vaccines
- Polysaccharide vaccines
- Subunit vaccines
6. Manufacturing and Regulatory
- Antigen production
- Formulation and quality control (QC)
- Scale-up and bioprocessing
- Cold chain management
7. Role of Adjuvants
- Enhancing immune responses
- Prolonging protection duration
- Improving vaccine efficacy
- Application in subunit vaccines
- Improving duration of protection
8. Specialized Areas
i)Cancer and HIV Vaccines
- Preventive vaccines
- Therapeutic vaccines
- Tumor antigens
ii)Vaccine Safety
- Preclinical testing
- Adverse event reporting
- Regulatory oversight
- Addressing vaccine hesitancy
iii)Coronavirus (COVID-19) Vaccine Research
Development and global efforts
Â
iv)Cancer Vaccines & Immunotherapy
Advances in personalized medicine
Â
v)HIV Vaccines
Breakthroughs and challenges
Â
9. Emerging Focus Areas
- Vaccine adjuvants
- Influenza vaccines
- Human vaccines – next-generation innovations
- Bioprocessing and manufacturing techniques
- Vaccine regulation and policy
- Conjugate vaccines
- Ebola vaccine
- Veterinary vaccines
10. Infectious & Non-Infectious Diseases
- Emerging diseases
- Re-emerging diseases
VCCINES2025 TOPICS COVERED
| Coronavirus (COVID-19) Vaccine Research |
| Bacterial and Viral, RSV, influenza |
| HIV Vaccines |
| New and Emerging vaccines: |
| Zika, Ebola, Marburg, Lassa fever, Dengue |
| Veterinary Vaccine |
| Cancer Vaccines & Immunotherapy |
| Vaccine Adjuvants |
| Conjugate Vaccine |
Â
| New Vaccine Development |
| Bioprocessing & Manufacturing |
| Human Vaccines-Next Generation |
Technology & Delivery Platforms & Emerging technologies |
| Manufacturing and Regulatory |
| Vaccine Process Development & Production |
| Vaccine Safety |
| Clinical Trials |
| Vaccine Business |
| Infectious & Non-Infectious Diseases |
| Emerging & Re-Emerging Diseases |
| Immunology and Immune System |
| Immunizable Diseases and their Vaccines |
| Immuno-Genetics & Immune Tolerance |
| Global Health Security and Immunization |
| Immunopathology |
| Infection and Immunity |
| Immunology & Research Advances |
STANDARD REGISTRATION CLOSES SOON!
Hurry up to register your spot now!!